BioCentury
ARTICLE | Company News

Chinese investors launch HPV JV

May 25, 2018 9:21 PM UTC

Shanghai Institute of Biological Products Co. Ltd. (Shanghai, China), 6 Dimensions Capital and Renxian Bioscience Co. Ltd. launched a JV -- Shanghai Zhicheng Bioscience Co. Ltd. -- to develop quadrivalent HPV vaccines in China.

The JV has IP rights to quadrivalent HPV vaccine technology from the state-owned Shanghai Institute of Biological Products. The institute said its vaccines were developed according to Chinese epidemiological data and target HPV types 16, 18, 52, and 58. ...